Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation

Atrial fibrillation (AF) is associated with an increased risk of thromboembolism, and is the most prevalent factor for cardioembolic stroke. Vitamin K antagonists (VKAs) have been the standard of care for stroke prevention in patients with AF since the early 1990s. They are very effective for the pr...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Huber, K, Connolly, S J, Kher, A, Christory, F, Dan, G-A, Hatala, R, Kiss, R G, Meier, B, Merkely, B, Pieske, B, Potpara, T, Stępińska, J, Klun, N Vene, Vinereanu, D, Widimský, P
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Blackwell Publishing Ltd 2013
Θέματα:
Cardiovascular
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3712459/
https://ncbi.nlm.nih.gov/pubmed/23557519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijcp.12147
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια